P2RY8 is a G protein-coupled receptor that functions as a key regulator of B cell positioning and growth within lymphoid organs. The receptor couples to GNA13 signaling pathways and serves as a negative regulator of lymphocyte trafficking and proliferation 1. In germinal centers, P2RY8 promotes B cell confinement and restricts cell migration, with variants affecting surface expression, migration, and proliferation through pleiotropic mechanisms 2. The receptor plays a critical role in immunological tolerance, as germline P2RY8 variants are associated with lupus pathogenesis, where reduced P2RY8 expression correlates with lupus nephritis and increased plasma cell development 3. P2RY8 rearrangements, particularly P2RY8-CRLF2 fusions, are clinically significant in B-cell acute lymphoblastic leukemia (B-ALL), occurring in 3-5% of pediatric cases and associated with worse treatment response, higher minimal residual disease, and significantly reduced event-free survival 45. These rearrangements identify a high-risk subset of B-ALL patients requiring intensified treatment protocols. Additionally, P2RY8 alterations are found in primary mediastinal B-cell lymphomas, contributing to the genetic landscape of these aggressive malignancies 6.